Incidence of SARS-CoV-2 (COVID-19) -associated pulmonary aspergillosis (CAPA) before and after dexamethasone therapy - a retrospective analysis

Recruiting

• Conditions: B44.0; Invasive pulmonary aspergillosis

• Registration Number: DRKS00026071
• Lead Sponsor: niversitätsklinikum Essen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-08-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

COVID-19
Pneumonia
Asp-Ag positive
or
culture pos
or
PCR pos

Exclusion Criteria

not fullfilled inclusion criteria

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurence of CAPA

Secondary Outcome Measures

Name	Time	Method
severity of illness